More evidence is needed to determine what effect, if any, antioxidants such as vitamin C have on chemotherapy
Body weight, body composition, muscle size, and direct measurements of muscle strength were collected before and after treatment
until it was eventually banned by the FDA in December 2003 due to its risk of cardiovascular adverse effects (AEs).6 This case illustrates the risk associated with the current situation in the U.S., where medications extracted from plants might not be allowed to be marketed as medications
This NO modulation affects blood flow, inflammation, and cellular signaling throughout healing tissues
Larger, more diverse clinical trials are essential to fill these gaps, enabling patients to make informed treatment decisions while considering the potential risks associated with Semaglutide